Following is a list of selected publications:
- NKX2-1 drives neuroendocrine transdifferentiation of prostate cancer via epigenetic and 3D chromatin remodeling.
Nat Genet Volume: 57 Page(s): 1966 - 1980
08/01/2025 Authors: Lu X; Keo V; Cheng I; Xie W; Gritsina G; Wang J; Lu L; Shiau C-K; He Y; Jin Q
- Sociodemographic Features, Health Care Costs, and Treatment Implications of Genomic Classifier Testing for Localized Prostate Cancer in the United States.
JCO Precis Oncol Volume: 9 Page(s): e2500406
08/01/2025 Authors: Janopaul-Naylor JR; Patil D; Joshi S; Sanda MG; Sebastian N; Salari K; Dodge J; Dhere VR; Hershatter BW; Patel PR
- Utilization, health care expenditures, and patient costs of definitive treatment modalities for localized prostate cancer in the United States.
Cancer Volume: 131 Page(s): e35795
03/15/2025 Authors: Sebastian NT; Patil D; Patel PR; Jani AB; Hershatter BW; Dhere VR; Godette KD; Lorentz CA; Weiss AD; Joshi SS
- A simplified MyProstateScore2.0 for high-grade prostate cancer.
Cancer Biomark Volume: 42 Page(s): 18758592241308755
01/01/2025 Authors: Tang TM; Zhang Y; Kenney AM; Xie C; Xiao L; Siddiqui J; Srivastava S; Sanda MG; Wei JT; Feng Z
- Differentiation fate of a stem-like CD4 T cell controls immunity to cancer.
Nature Volume: 636 Page(s): 224 - 232
12/01/2024 Authors: Cardenas MA; Prokhnevska N; Sobierajska E; Gregorova P; Medina CB; Valanparambil RM; Greenwald R; DelBalzo L; Bilen MA; Joshi SS
- Upgrading of Grade Group 1 Prostate Cancer at Prostatectomy: Germline Risk Factors in a Prospective Cohort.
Cancer Epidemiol Biomarkers Prev Volume: 33 Page(s): 1500 - 1511
11/01/2024 Authors: Liss MA; Zeltser N; Zheng Y; Lopez C; Liu M; Patel Y; Yamaguchi TN; Eng SE; Tian M; Semmes OJ
- The diagnostic challenges of differentiating metastatic extramammary Paget disease and prostatic adenocarcinoma: A case report and review of the literature.
Urol Case Rep Volume: 57 Page(s): 102875
11/01/2024 Authors: Palmateer G; Nicaise EH; Gandhi J; Goodstein T; Sheng M; Ogan K; Kucuk O; Yushak M; Sanda MG; Delman KA
- Author Correction: Differentiation fate of a stem-like CD4 T cell controls immunity to cancer.
Nature Volume: 635 Page(s): E9
11/01/2024 Authors: Cardenas MA; Prokhnevska N; Sobierajska E; Gregorova P; Medina CB; Valanparambil RM; Greenwald R; DelBalzo L; Bilen MA; Joshi SS
- Postprostatectomy Radiotherapy Timing and Long-Term Health-Related Quality of Life.
JAMA Netw Open Volume: 7 Page(s): e2440747
10/01/2024 Authors: Patel SA; Patil D; Smith J; Saigal CS; Litwin MS; Hu JC; Cooperberg MR; Carroll PR; Klein EA; Kibel AS
- Development and Validation of an 18-Gene Urine Test for High-Grade Prostate Cancer.
JAMA Oncol Volume: 10 Page(s): 726 - 736
06/01/2024 Authors: Tosoian JJ; Zhang Y; Xiao L; Xie C; Samora NL; Niknafs YS; Chopra Z; Siddiqui J; Zheng H; Herron G
- Integrated Genomic Analysis of Primary Prostate Tumor Foci and Corresponding Lymph Node Metastases Identifies Mutations and Pathways Associated with Metastasis.
Cancers (Basel) Volume: 15
11/30/2023 Authors: Moreno CS; Winham CL; Alemozaffar M; Klein ER; Lawal IO; Abiodun-Ojo OA; Patil D; Barwick BG; Huang Y; Schuster DM
- Effect of Brachytherapy With External Beam Radiation Therapy Versus Brachytherapy Alone for Intermediate-Risk Prostate Cancer: NRG Oncology RTOG 0232 Randomized Clinical Trial.
J Clin Oncol Volume: 41 Page(s): 4035 - 4044
08/20/2023 Authors: Michalski JM; Winter KA; Prestidge BR; Sanda MG; Amin M; Bice WS; Gay HA; Ibbott GS; Crook JM; Catton CN
- Covariate-specific evaluation of continuous biomarker.
Stat Med Volume: 42 Page(s): 953 - 969
03/30/2023 Authors: Li Z; Huang Y; Patil D; Rubin M; Sanda MG
- Covariate adjustment in continuous biomarker assessment.
Biometrics Volume: 79 Page(s): 39 - 48
03/01/2023 Authors: Li Z; Huang Y; Patil D; Sanda MG
- CD8+ T cell activation in cancer comprises an initial activation phase in lymph nodes followed by effector differentiation within the tumor.
Immunity Volume: 56 Page(s): 107 - 124.e5
01/10/2023 Authors: Prokhnevska N; Cardenas MA; Valanparambil RM; Sobierajska E; Barwick BG; Jansen C; Reyes Moon A; Gregorova P; delBalzo L; Greenwald R
- Interval estimation for operating characteristic of continuous biomarkers with controlled sensitivity or specificity.
Stat Sin Volume: 33 Page(s): 193 - 214
01/01/2023 Authors: Huang Y; Parakati I; Patil DH; Sanda MG
- Invariant NKT cell-augmented GM-CSF-secreting tumor vaccine is effective in advanced prostate cancer model.
Cancer Immunol Immunother Volume: 71 Page(s): 2943 - 2955
12/01/2022 Authors: Varghese B; Lynch L; Vriend LE; Draganov D; Clark JM; Kissick HT; Varghese S; Sanda MG; Dranoff G; Arredouani MS
- Impact of Prostate Health Index Results for Prediction of Biopsy Grade Reclassification During Active Surveillance.
J Urol Volume: 208 Page(s): 1037 - 1045
11/01/2022 Authors: Filson CP; Zhu K; Huang Y; Zheng Y; Newcomb LF; Williams S; Brooks JD; Carroll PR; Dash A; Ellis WJ
- Cost-effectiveness analysis of primary treatments for localised prostate cancer: A population-based Markov analysis using real-world evidence.
Eur J Cancer Care (Engl) Volume: 31 Page(s): e13740
11/01/2022 Authors: Weng X; Zhong L; Xiang P; Li Y; Paciorek A; Dong L; Broering J; Carroll PR; Sanda M; Wilson L
- LINEAR BIOMARKER COMBINATION FOR CONSTRAINED CLASSIFICATION.
Ann Stat Volume: 50 Page(s): 2793 - 2815
10/01/2022 Authors: Huang Y; Sanda MG
- Patient reported outcomes for quality of life (QOL) by Expanded Prostate Cancer Index (EPIC) on average 15 years post treatment.
Clin Transl Radiat Oncol Volume: 36 Page(s): 56 - 62
09/01/2022 Authors: Seymour ZA; Daignault-Newton S; McLaughlin PW; Sandler H; Jackson W; Johnson SB; Miller D; Wei J; Sanda M; Hamstra DA
- High throughput, label-free isolation of circulating tumor cell clusters in meshed microwells.
Nat Commun Volume: 13 Page(s): 3385
06/13/2022 Authors: Boya M; Ozkaya-Ahmadov T; Swain BE; Chu C-H; Asmare N; Civelekoglu O; Liu R; Lee D; Tobia S; Biliya S
- Association of race with receipt of definitive therapy for high risk prostate cancer in older men.
J Geriatr Oncol Volume: 13 Page(s): 200 - 206
03/01/2022 Authors: Patel SA; Liu Y; Mahal BA; Jani AB; Sanda MG; Royce TJ; Fischer-Valuck BW
- Treatment Patterns and Overall Survival Outcomes Among Patients Aged 80 yr or Older with High-risk Prostate Cancer.
Eur Urol Open Sci Volume: 37 Page(s): 80 - 89
03/01/2022 Authors: Fischer-Valuck BW; Baumann BC; Brown SA; Filson CP; Weiss A; Mueller R; Liu Y; Brenneman RJ; Sanda M; Michalski JM
- Collision tumors revealed by prospectively assessing subtype-defining molecular alterations in 904 individual prostate cancer foci.
JCI Insight Volume: 7
02/22/2022 Authors: Fontugne J; Cai PY; Alnajar H; Bhinder B; Park K; Ye H; Beg S; Sailer V; Siddiqui J; Blattner-Johnson M
- Cancer-specific outcomes for prostate cancer patients who had prebiopsy prostate MRI.
Urol Oncol Volume: 40 Page(s): 58.e9 - 58.e15
02/01/2022 Authors: Li J; Patil D; Sanda MG; Filson CP
- Genetic Factors Associated with Prostate Cancer Conversion from Active Surveillance to Treatment.
HGG Adv Volume: 3
01/13/2022 Authors: Jiang Y; Meyers TJ; Emeka AA; Cooley LF; Cooper PR; Lancki N; Helenowski I; Kachuri L; Lin DW; Stanford JL
- Prospective Multicenter Comparison of Open and Robotic Radical Prostatectomy: The PROST-QA/RP2 Consortium.
J Urol Volume: 207 Page(s): 127 - 136
01/01/2022 Authors: Chang P; Wagner AA; Regan MM; Smith JA; Saigal CS; Litwin MS; Hu JC; Cooperberg MR; Carroll PR; Klein EA
- CD8 T CELL ACTIVATION IN CANCER IS COMPRISED OF TWO DISTINCT PHASES
Volume: 9 Page(s): A686 - A686
11/01/2021 Authors: Prokhnevska N; Cardenas M; Valanparambil R; Sobierajska E; Jansen C; Master V; Sanda M; Kissick H
- UTILITY OF DIGITAL RECTAL EXAM FOR PROSTATE CANCER SCREENING AMONG MEN WITH LOW PSA VALUES
Volume: 206 Page(s): E471 - E471
09/01/2021 Authors: Brownfield C; Harik L; Kowalczyk K; Patil D; Sanda M; Osunkoya A; Filson C
- PROSTATE HEALTH INDEX IN PREDICTING GRADE RECLASSIFICATION ON BIOPSY FOR MEN ON ACTIVE SURVEILLANCE
Volume: 206 Page(s): E1095 - E1096
09/01/2021 Authors: Filson C; Sokoll L; Zheng Y; Huang Y; Newcomb L; Zhu K; Williams S; Sanda M; Chan D; Lin D
- Disparities in magnetic resonance imaging of the prostate for traditionally underserved patients with prostate cancer.
Cancer Volume: 127 Page(s): 2974 - 2979
08/15/2021 Authors: Quinn TP; Sanda MG; Howard DH; Patil D; Filson CP
- Decision regret, adverse outcomes, and treatment choice in men with localized prostate cancer: Results from a multi-site randomized trial.
Urol Oncol Volume: 39 Page(s): 493.e9 - 493.e15
08/01/2021 Authors: Berry DL; Hong F; Blonquist TM; Halpenny B; Xiong N; Filson CP; Master VA; Sanda MG; Chang P; Chien GW
- CD8 T cell differentiation in cancer is comprised of two distinct phases
Volume: 206
05/01/2021 Authors: Prokhnevska N; Cardenas M; Valanparambil R; Jansen C; Master V; Sanda M; Kissick H
- A panel of selected serum protein biomarkers for the detection of aggressive prostate cancer.
Theranostics Volume: 11 Page(s): 6214 - 6224
01/01/2021 Authors: Song J; Ma S; Sokoll LJ; Eguez RV; Höti N; Zhang H; Mohr P; Dua R; Patil D; May KD
- Prostate Cancer Biomarker Development: National Cancer Institute's Early Detection Research Network Prostate Cancer Collaborative Group Review.
Cancer Epidemiol Biomarkers Prev Volume: 29 Page(s): 2454 - 2462
12/01/2020 Authors: Liss MA; Leach RJ; Sanda MG; Semmes OJ
- External Validation of Early Quality of Life (QOL) Declines Correlated with Late QOL after Intensity Modulated, Low Dose Rate Brachytherapy, or Stereotactic Radiation for Prostate Cancer within a Prospective Trial
Volume: 108 Page(s): S69 - S69
11/01/2020 Authors: Seymour ZA; Hamstra DA; Daignault-Newton S; Thompson A; Sanda MG; Michalski JM; Zietman AL; Kuban DA; Ciezki JP; Kaplan ID
- [18F]Fluciclovine Positron Emission Tomography/Computerized Tomography for Preoperative Staging in Patients with Intermediate to High Risk Primary Prostate Cancer.
J Urol Volume: 204 Page(s): 734 - 740
10/01/2020 Authors: Alemozaffar M; Akintayo AA; Abiodun-Ojo OA; Patil D; Saeed F; Huang Y; Osunkoya AO; Goodman MM; Sanda M; Schuster DM
- In-Bore MRI-guided Prostate Biopsies in Patients with Prior Positive Transrectal US-guided Biopsy Results: Pathologic Outcomes and Predictors of Missed Cancers.
Radiol Imaging Cancer Volume: 2 Page(s): e190078
09/25/2020 Authors: Elfatairy KK; Filson CP; Sanda MG; Osunkoya AO; Nour SG
- Cancer and Leukemia Group B 90203 (Alliance): Radical Prostatectomy With or Without Neoadjuvant Chemohormonal Therapy in Localized, High-Risk Prostate Cancer.
J Clin Oncol Volume: 38 Page(s): 3042 - 3050
09/10/2020 Authors: Eastham JA; Heller G; Halabi S; Monk JP; Beltran H; Gleave M; Evans CP; Clinton SK; Szmulewitz RZ; Coleman J
- [18F]fluciclovine PET/CT versus multiparametric MRI assessment of seminal vesicle invasion and extracapsular extension in patients with primary prostate cancer.
Volume: 61
05/01/2020 Authors: Akintayo A; Abiodun-Ojo O; Alemozaffar M; Akin-Akintayo O; Patil D; Huang Y; Osunkoya A; Sanda M; Schuster D
- Tumor-specific CD8 T cell activation in draining lymph nodes supports the anti-tumor CD8 T cell response
Volume: 204
05/01/2020 Authors: Prokhnevska N; Cardenas M; Jansen C; Valanparambil R; Master V; Sanda M; Kissick H
- A prospective study of patient reported urinary incontinence among American, Norwegian and Spanish men 1 year after prostatectomy.
Asian J Urol Volume: 7 Page(s): 161 - 169
04/01/2020 Authors: Storås AH; Sanda MG; Garin O; Chang P; Patil D; Crociani C; Suarez JF; Cvancarova M; Loge JH; Fosså SD
- DISPARITIES IN USE OF PREBIOPSY PROSTATE MAGNETIC RESONANCE IMAGING FOR MEDICARE-ELIGIBLE PROSTATE CANCER PATIENTS
Volume: 203 Page(s): E817 - E817
04/01/2020 Authors: Quinn T; Patil D; Sanda M; Howard D; Filson C
- IMPACT OF PREBIOPSY PROSTATE MRI ON BIOPSY RESULTS, INITIAL TREATMENT, AND PROSTATECTOMY OUTCOMES FOR MEDICARE-ELIGIBLE PROSTATE CANCER PATIENTS
Volume: 203 Page(s): E806 - E806
04/01/2020 Authors: Li J; Patil D; Sanda M; Howard D; Filson C
- PREOPERATIVE F-18-FLUCICLOVINE PET/CT FINDINGS MAY BE PREDICTIVE OF POST-OPERATIVE PROSTATE-SPECIFIC ANTIGEN (PSA) IN PATIENTS WITH HIGH RISK PROSTATE CANCER
Volume: 203 Page(s): E1026 - E1026
04/01/2020 Authors: Akintayo A; Abiodun-Ojo O; Alemozaffar M; Akin-Akintayo O; Patil D; Osunkoya A; Sanda M; Schuster D
- An intra-tumoral niche maintains and differentiates stem-like CD8 T cells.
Nature Volume: 576 Page(s): 465 - 470
12/01/2019 Authors: Jansen CS; Prokhnevska N; Master VA; Sanda MG; Carlisle JW; Bilen MA; Cardenas M; Wilkinson S; Lake R; Sowalsky AG
- How tumor-specific CD8 T cell activation in draining lymph nodes supports the anti-tumor CD8 T cell response
Volume: 7
11/06/2019 Authors: Prokhnevska N; Valanparambil R; Jansen C; Master V; Sanda M; Kissick H
- In-Bore MRI-guided Prostate Biopsies: Retrospective Observational Study of Complementary Nontargeted Sampling of Normal-appearing Areas at Multiparametric MRI.
Radiol Imaging Cancer Volume: 1 Page(s): e190016
11/01/2019 Authors: Elfatairy KK; Filson CP; Sanda MG; Osunkoya AO; Nour SG
- A four-group urine risk classifier for predicting outcomes in patients with prostate cancer.
BJU Int Volume: 124 Page(s): 609 - 620
10/01/2019 Authors: Connell SP; Yazbek-Hanna M; McCarthy F; Hurst R; Webb M; Curley H; Walker H; Mills R; Ball RY; Sanda MG
- Rise in Node-Positive Prostate Cancer Incidence in Context of Evolving Use and Extent of Pelvic Lymphadenectomy.
Clin Genitourin Cancer Volume: 17 Page(s): e494 - e504
06/01/2019 Authors: Taylor MA; Alemozaffar M; Master VA; Sanda MG; Filson CP
- Circulating microRNAs in plasma among men with low-grade and high-grade prostate cancer at prostate biopsy.
Prostate Volume: 79 Page(s): 961 - 968
06/01/2019 Authors: McDonald AC; Vira M; Walter V; Shen J; Raman JD; Sanda MG; Patil D; Taioli E
- Expanded Prostate Cancer Index Composite-26 (EPIC-26) Online: Validation of an Internet-Based Instrument for Assessment of Health-Related Quality of Life After Treatment for Localized Prostate Cancer.
Urology Volume: 127 Page(s): 53 - 60
05/01/2019 Authors: Einstein DJ; Patil D; Chipman J; Regan MM; Davis K; Crociani CM; Wagner AA; Sanda MG; Chang P
- Preoperative staging in high risk prostate cancer patients using F-18] fluctclovine PET/CT
Volume: 60
05/01/2019 Authors: Akintayo A; Abiodun-Ojo O; Alemozaffar M; Osunkoya A; Sanda M; Schuster D
- [F-18] fluciclovine PET/CT is superior to conventional imaging in preoperative nodal staging in patients with high-risk prostate cancer
Volume: 60
05/01/2019 Authors: Akintayo A; Abiodun-Ojo O; Alemozaffar M; Osunkoya A; Sanda M; Schuster D
- EVALUATION OF FLUCICLOVINE (FACBC) PET SCAN FOR STAGING HIGH-RISK PROSTATE CANCER BEFORE PRIMARY TREATMENT
Volume: 201 Page(s): E396 - E396
04/01/2019 Authors: Alemozaffar M; Akintayo A; Abiodun-Ojo O; Huang E; Patil D; Giles S; Torlak M; Sanda M; Schuster D
- Impact of prebiopsy magnetic resonance imaging of the prostate on cancer detection and treatment patterns.
Urol Oncol Volume: 37 Page(s): 181.e15 - 181.e21
03/01/2019 Authors: Liu W; Patil D; Howard DH; Moore RH; Wang H; Sanda MG; Filson CP
- Evaluating Clinical Implementation Approaches for Prostate Cancer Decision Support.
Urol Pract Volume: 6 Page(s): 93 - 99
03/01/2019 Authors: Berry DL; Hong F; Halpenny B; Sanda MG; Master VA; Filson CP; Chang P; Chien GW; Underhill M; Fox E
- Genitourinary Prosthetic Use among Prostate Cancer Survivors Treated with Radical Prostatectomy.
Urol Pract Volume: 6 Page(s): 123 - 128
03/01/2019 Authors: Aliperti LA; Patil D; Filson CP; Hartsell LM; Carney KJ; Sanda MG; Mehta A
- Safety of high dose rate prostate brachytherapy in patients with high baseline international prostate symptom scores.
Volume: 37
03/01/2019 Authors: Morgan T; Rossi PJ; Cutrell P; Zhang C; Press RH; Rahnema S; Sanda MG; Pattaras J; Cimmino CB; Jani AB
- Elevated Serum Cytokines and Trichomonas vaginalis Serology at Diagnosis Are Not Associated With Higher Gleason Grade or Lethal Prostate Cancer.
Clin Genitourin Cancer Volume: 17 Page(s): 32 - 37
02/01/2019 Authors: Vicier C; Werner L; Chipman J; Harshman LC; Patil DH; Fichorova RN; Rider JR; Sanda MG; Mucci LA; Sweeney CJ
- Assigning value to preparation for prostate cancer decision making: a willingness to pay analysis.
BMC Med Inform Decis Mak Volume: 19 Page(s): 6
01/09/2019 Authors: Wilson LS; Blonquist TM; Hong F; Halpenny B; Wolpin S; Chang P; Filson CP; Master VA; Sanda MG; Chien GW
- Incorporation of Urinary Prostate Cancer Antigen 3 and TMPRSS2:ERG into Prostate Cancer Prevention Trial Risk Calculator.
Eur Urol Focus Volume: 5 Page(s): 54 - 61
01/01/2019 Authors: Ankerst DP; Goros M; Tomlins SA; Patil D; Feng Z; Wei JT; Sanda MG; Gelfond J; Thompson IM; Leach RJ
- Patient-reported health-related quality of life outcomes after HDR brachytherapy between small (<60 cc) and large (≥60 cc) prostate glands.
Brachytherapy Volume: 18 Page(s): 13 - 21
01/01/2019 Authors: Press RH; Morgan TM; Cutrell PK; Zhang C; Chen Z; Rahnema S; Sanda M; Pattaras J; Patel P; Jani AB
- epiCaPture: A Urine DNA Methylation Test for Early Detection of Aggressive Prostate Cancer.
JCO Precis Oncol Volume: 2019
01/01/2019 Authors: O'Reilly E; Tuzova AV; Walsh AL; Russell NM; O'Brien O; Kelly S; Dhomhnallain ON; DeBarra L; Dale CM; Brugman R
- High-dose-rate prostate brachytherapy appears safe in patients with high baseline International Prostate Symptom Scores.
Brachytherapy Volume: 18 Page(s): 793 - 799
01/01/2019 Authors: Morgan TM; Rossi PJ; Cutrell PK; Zhang C; Press RH; Rahnema S; Sanda M; Pattaras J; Cimmino C; Hershatter B
- Brachytherapy for localized prostate cancer in the modern era: a comparison of patient-reported quality of life outcomes among different techniques.
J Contemp Brachytherapy Volume: 10 Page(s): 495 - 502
12/01/2018 Authors: Morgan TM; Press RH; Cutrell PK; Zhang C; Chen Z; Rahnema S; Sanda M; Pattaras J; Patel PR; Jani AB
- Adoption of Prebiopsy Magnetic Resonance Imaging for Men Undergoing Prostate Biopsy in the United States.
Urology Volume: 117 Page(s): 57 - 63
07/01/2018 Authors: Liu W; Patil D; Howard DH; Moore RH; Wang H; Sanda MG; Filson CP
- Hypofractionated external beam radiation therapy in combination with HDR boost for localized prostate cancer: patient reported quality of life outcomes.
J Contemp Brachytherapy Volume: 10 Page(s): 211 - 217
06/01/2018 Authors: Morgan TM; Press RH; Cutrell PK; Zhang C; Chen Z; Rahnema S; Jhaveri J; Sanda M; Pattaras J; Patel P
- Circulating microRNAs in plasma as potential biomarkers for the early detection of prostate cancer.
Prostate Volume: 78 Page(s): 411 - 418
05/01/2018 Authors: McDonald AC; Vira M; Shen J; Sanda M; Raman JD; Liao J; Patil D; Taioli E
-
HYPERLINK "https://med.emory.edu/directory/profile/?u=MSANDA"Patient-reported outcomes after treatment for clinically localized prostate cancer: A systematic review and meta-analysis.
Cancer Treat Rev Volume: 66 Page(s): 23 - 44
05/01/2018 Authors: Ávila M; Patel L; López S; Cortés-Sanabria L; Garin O; Pont À; Ferrer F; Boladeras A; Zamora V; Fosså S
- Predictors of Patient and Partner Satisfaction Following Radical Prostatectomy.
Sex Med Rev Volume: 6 Page(s): 295 - 301
04/01/2018 Authors: Guercio C; Mehta A
- In-bore MRI-guided biopsy: can it optimize the need for periodic biopsies in prostate cancer patients undergoing active surveillance? A pilot test-retest reliability study.
Br J Radiol Volume: 91 Page(s): 20170603
04/01/2018 Authors: Elfatairy KK; Filson CP; Sanda MG; Osunkoya AO; Geller RL; Nour SG
- Clinically Localized Prostate Cancer: AUA/ASTRO/SUO Guideline. Part II: Recommended Approaches and Details of Specific Care Options.
J Urol Volume: 199 Page(s): 990 - 997
04/01/2018 Authors: Sanda MG; Cadeddu JA; Kirkby E; Chen RC; Crispino T; Fontanarosa J; Freedland SJ; Greene K; Klotz LH; Makarov DV
- PROSTATE BIOPSY COSTS FOR PRIVATELY-INSURED MEN: IMPACT OF MAGNETIC RESONANCE IMAGE-GUIDANCE AND USE OF ANESTHESIA SERVICES
Volume: 199 Page(s): E1023 - E1023
04/01/2018 Authors: Leung A; Liu W; Patil D; Henry M; Howard D; Wang H; Moore R; Sanda M; Filson C
- DETECTION OF PROSTATE CANCER-ASSOCIATED TRANSCRIPTS IN URINARY EXTRACELLULAR VESICLES
Volume: 199 Page(s): E450 - E451
04/01/2018 Authors: Pellegrini K; Patil D; Douglas K; Anastasiades E; Larsen K; Kim F; Catic A; Torlak M; Huang E; Moreno C
- Clinically Localized Prostate Cancer: AUA/ASTRO/SUO Guideline. Part I: Risk Stratification, Shared Decision Making, and Care Options.
J Urol Volume: 199 Page(s): 683 - 690
03/01/2018 Authors: Sanda MG; Cadeddu JA; Kirkby E; Chen RC; Crispino T; Fontanarosa J; Freedland SJ; Greene K; Klotz LH; Makarov DV
- Hypofractionated external beam radiation therapy in combination with HDR boost for localized prostate cancer: Quality of life outcomes.
Volume: 36
02/20/2018 Authors: Morgan T; Press RH; Cutrell P; Zhang C; Chen Z; Rahnema S; Sanda MG; Pattaras J; Patel PR; Jani AB
- NATIONWIDE UTILIZATION OF RECONSTRUCTIVE UROLOGICAL PROCEDURES TO MITIGATE SEXUAL AND URINARY COMPLICATIONS FOLLOWING RADICAL PROSTATECTOMY
Volume: 15 Page(s): S91 - S91
02/01/2018 Authors: Aliperti L; Patil D; Filson C; Carney K; Sanda M; Mehta A
- Decision Support with the Personal Patient Profile-Prostate: A Multicenter Randomized Trial.
J Urol Volume: 199 Page(s): 89 - 97
01/01/2018 Authors: Berry DL; Hong F; Blonquist TM; Halpenny B; Filson CP; Master VA; Sanda MG; Chang P; Chien GW; Jones RA
- Predicting erectile function following external beam radiation therapy or brachytherapy for prostate cancer using EPIC-CP.
Pract Radiat Oncol Volume: 8 Page(s): 445 - 451
01/01/2018 Authors: Mihalcik SA; Chipman JJ; Sanda MG; Regan MM; Kaplan ID; Wagner AA; Crociani CM; Chang P; PROST-QA Consortium
- Patients with Intermediate Risk Prostate Cancer May be Good Candidates for Active Surveillance: Pro.
J Urol Volume: 198 Page(s): 997 - 999
11/01/2017 Authors: Sanda MG
- Early Adoption of MRI-Guided Prostate Biopsies Rose Rapidly among Men with Private Health Insurance
Volume: 225 Page(s): S114 - S115
10/01/2017 Authors: Liu W; Patil D; Howard DH; Moore RH; Wang H; Sanda MG; Filson CP
- Association Between Combined TMPRSS2:ERG and PCA3 RNA Urinary Testing and Detection of Aggressive Prostate Cancer.
JAMA Oncol Volume: 3 Page(s): 1085 - 1093
08/01/2017 Authors: Sanda MG; Feng Z; Howard DH; Tomlins SA; Sokoll LJ; Chan DW; Regan MM; Groskopf J; Chipman J; Patil DH
- Gleason Score 7 Prostate Cancers Emerge through Branched Evolution of Clonal Gleason Pattern 3 and 4.
Clin Cancer Res Volume: 23 Page(s): 3823 - 3833
07/15/2017 Authors: Sowalsky AG; Kissick HT; Gerrin SJ; Schaefer RJ; Xia Z; Russo JW; Arredouani MS; Bubley GJ; Sanda MG; Li W
- Prostate Health Index improves multivariable risk prediction of aggressive prostate cancer.
BJU Int Volume: 120 Page(s): 61 - 68
07/01/2017 Authors: Loeb S; Shin SS; Broyles DL; Wei JT; Sanda M; Klee G; Partin AW; Sokoll L; Chan DW; Bangma CH
- Racial Variation in the Utility of Urinary Biomarkers PCA3 and T2ERG in a Large Multicenter Study.
J Urol Volume: 198 Page(s): 42 - 49
07/01/2017 Authors: O'Malley PG; Nguyen DP; Al Hussein Al Awamlh B; Wu G; Thompson IM; Sanda M; Rubin M; Wei JT; Lee R; Christos P
- Evaluation of a 24-gene signature for prognosis of metastatic events and prostate cancer-specific mortality.
BJU Int Volume: 119 Page(s): 961 - 967
06/01/2017 Authors: Pellegrini KL; Sanda MG; Patil D; Long Q; Santiago-Jiménez M; Takhar M; Erho N; Yousefi K; Davicioni E; Klein EA
- Detection of prostate cancer-specific transcripts in extracellular vesicles isolated from post-DRE urine.
Prostate Volume: 77 Page(s): 990 - 999
06/01/2017 Authors: Pellegrini KL; Patil D; Douglas KJS; Lee G; Wehrmeyer K; Torlak M; Clark J; Cooper CS; Moreno CS; Sanda MG
- External Beam Radiation Therapy or Brachytherapy With or Without Short-course Neoadjuvant Androgen Deprivation Therapy: Results of a Multicenter, Prospective Study of Quality of Life.
Int J Radiat Oncol Biol Phys Volume: 98 Page(s): 304 - 317
06/01/2017 Authors: Gay HA; Sanda MG; Liu J; Wu N; Hamstra DA; Wei JT; Dunn RL; Klein EA; Sandler HM; Saigal CS
- Neoadjuvant Enzalutamide Prior to Prostatectomy.
Clin Cancer Res Volume: 23 Page(s): 2169 - 2176
05/01/2017 Authors: Montgomery B; Tretiakova MS; Joshua AM; Gleave ME; Fleshner N; Bubley GJ; Mostaghel EA; Chi KN; Lin DW; Sanda M
- PERSONALIZED DECISION SUPPORT FOR LOCALIZED PROSTATE CANCER: RESULTS OF A MULTI-SITE RANDOMIZED TRIAL
Volume: 197 Page(s): E122 - E122
04/01/2017 Authors: Berry D; Hong F; Blonquist T; Halpenny B; Sanda M; Master V; Filson C; Rossi P; Chang P; Chien G
- POPULATION-LEVEL CANCER DETECTION AND PATTERNS OF CARE FOLLOWING MRI-GUIDED PROSTATE BIOPSY
Volume: 197 Page(s): E93 - E94
04/01/2017 Authors: Liu W; Patil D; Howard D; Moore R; Wang H; Sanda M; Filson C
- A PATIENT-CENTERED PRACTICE CHANGE: FINDING THE BEST APPROACH FOR PROSTATE CANCER DECISION SUPPORT
Volume: 197 Page(s): E933 - E933
04/01/2017 Authors: Berry D; Halpenny B; Underhill M; Sanda M; Master V; Filson C; Chang P; Chien G; Wolpin S
- Targeted RNA Sequencing of FFPE Prostate Biopsies and Matched Prostatectomies
Volume: 31
04/01/2017 Authors: Sharma NV; Pellegrini KL; Osunkoya AO; Gillespie T; Petros J; Huang E; Sanda MG; Moreno CS
- Relief of Urinary Symptom Burden after Primary Prostate Cancer Treatment.
J Urol Volume: 197 Page(s): 376 - 384
02/01/2017 Authors: Chang P; Regan MM; Ferrer M; Guedea F; Patil D; Wei JT; Hembroff LA; Michalski JM; Saigal CS; Litwin MS
- PREDICTORS OF PATIENT AND PARTNER REPORTED SEXUAL SATISFACTION FOLLOWING RADICAL PROSTATECTOMY
Volume: 14 Page(s): E81 - E82
02/01/2017 Authors: Mehta A; Patil D; Goodman M; Sanda MG
- Clinical Use of Expanded Prostate Cancer Index Composite for Clinical Practice to Assess Patient Reported Prostate Cancer Quality of Life Following Robot-Assisted Radical Prostatectomy.
J Urol Volume: 197 Page(s): 109 - 114
01/01/2017 Authors: Wagner AA; Cheng PJ; Carneiro A; Dovirak O; Khosla A; Taylor KN; Crociani CM; McAnally KC; Percy A; Dewey LE
- Multinational Prospective Study of Patient-Reported Outcomes After Prostate Radiation Therapy: Detailed Assessment of Rectal Bleeding.
Int J Radiat Oncol Biol Phys Volume: 96 Page(s): 770 - 777
11/15/2016 Authors: Lee JY; Daignault-Newton S; Heath G; Scarlett S; Sanda MG; Chang P; Regan MM; Michalski JM; Sandler HM; Feng FY
- Initial Report of NRG Oncology/RTOG 0232: A Phase 3 Study Comparing Combined External Beam Radiation and Transperineal Interstitial Permanent Brachytherapy With Brachytherapy Alone for Selected Patients With Intermediate-Risk Prostatic Carcinoma.
Int J Radiat Oncol Biol Phys Volume: 96 Page(s): S4
10/01/2016 Authors: Prestidge BR; Winter K; Sanda MG; Amin M; Bice WS; Michalski J; Ibbott GS; Crook JM; Catton CN; Gay HA
- Erectile Dysfunction and Sexual Problems Two to Three Years After Prostatectomy Among American, Norwegian, and Spanish Patients.
Clin Genitourin Cancer Volume: 14 Page(s): e265 - e273
06/01/2016 Authors: Storås AH; Sanda MG; Boronat OG; Chang P; Patil D; Crociani C; Suarez JF; Cvancarova M; Loge JH; Fosså SD
- Gleason Misclassification Rate Is Independent of Number of Biopsy Cores in Systematic Biopsy.
Urology Volume: 91 Page(s): 143 - 149
05/01/2016 Authors: Quintana L; Ward A; Gerrin SJ; Genega EM; Rosen S; Sanda MG; Wagner AA; Chang P; DeWolf WC; Ye H
- TARGETED SEQUENCING OF PROSTATE CANCER-ASSOCIATED RNAS IN EXTRACELLULAR VESICLES FROM POST-DRE URINE
Volume: 195 Page(s): E12 - E13
04/01/2016 Authors: Pellegrini K; Patil D; Douglas K; Wehrmeyer K; Bausum A; Torlak M; Sanda M; Moreno C
- PCA3 AND T2: ERG ADD FURTHER PREDICTIVE AND CLINICAL BENEFIT TO THE DETECTION OF PROSTATE CANCER IN MEN OF VARIOUS AGES IN THE EARLY DETECTION RESEARCH NETWORK (EDRN)
Volume: 195 Page(s): E249 - E250
04/01/2016 Authors: O'Malley P; Golombos DM; Lewicki P; Al Awamlh BAH; Christos PJ; Thompson IM; Sanda MG; Wei JT; Rubin MA; Barbieri CE
- Outcomes of Active Surveillance for Clinically Localized Prostate Cancer in the Prospective, Multi-Institutional Canary PASS Cohort.
J Urol Volume: 195 Page(s): 313 - 320
02/01/2016 Authors: Newcomb LF; Thompson IM; Boyer HD; Brooks JD; Carroll PR; Cooperberg MR; Dash A; Ellis WJ; Fazli L; Feng Z
- Dynamic correlation of serum C-reactive protein (CRP) levels with serum prostate-specific antigen (PSA) levels in patients with prostate cancer (PCa) on androgen deprivation therapy (ADT).
Volume: 34
01/10/2016 Authors: Kucuk O; Balci B; Liu Y; Zhang C; Yilmaz B; Atag E; Karaoglu A; Jani AB; Harris W; Carthon BC
- Pre-treatment nomogram to predict potency after treatment for localized prostate cancer
Volume: 34
01/10/2016 Authors: Zabell J; Sanda MG; Litwin MS; Suarez JF; Regan MM; Saigal C; Kwan L; Gao T; Rabah D; Klein EA
- Predicting return of erectile function following external beam radiotherapy or brachytherapy for prostate cancer using EPIC-CP.
Volume: 34
01/10/2016 Authors: Mihalcik SA; Chipman J; Sanda MG; Kaplan ID; Crociani C; Chang P
- RNA biomarkers to facilitate the identification of aggressive prostate cancer.
Mol Aspects Med Volume: 45 Page(s): 37 - 46
11/01/2015 Authors: Pellegrini KL; Sanda MG; Moreno CS
- Impact of Rectal Bleeding on Quality of Life Measures After Prostate Radiation Therapy: Comparison of the EPIC-26 and EPIC-CP Instruments
Volume: 93 Page(s): S201 - S201
11/01/2015 Authors: Lee JY; Scarlett S; Daignault-Newton S; Sanda MG; Michalski JM; Sandler HM; Kuban DA; Zietman AL; Ciezki JP; Kaplan ID
- Quality of life after primary treatment for localized prostate cancer: long-term considerations.
Eur Urol Volume: 68 Page(s): 609 - 610
10/01/2015 Authors: Alemozaffar M; Sanda MG
- The transcription factor ERG increases expression of neurotransmitter receptors on prostate cancer cells.
BMC Cancer Volume: 15 Page(s): 604
08/27/2015 Authors: Kissick HT; On ST; Dunn LK; Sanda MG; Asara JM; Pellegrini KL; Noel JK; Arredouani MS
- The role of active vaccination in cancer immunotherapy: lessons from clinical trials.
Curr Opin Immunol Volume: 35 Page(s): 15 - 22
08/01/2015 Authors: Kissick HT; Sanda MG
- Patient-reported quality of life after stereotactic body radiotherapy (SBRT), intensity modulated radiotherapy (IMRT), and brachytherapy.
Radiother Oncol Volume: 116 Page(s): 179 - 184
08/01/2015 Authors: Evans JR; Zhao S; Daignault S; Sanda MG; Michalski J; Sandler HM; Kuban DA; Ciezki J; Kaplan ID; Zietman AL
- Usability evaluation and adaptation of the e-health Personal Patient Profile-Prostate decision aid for Spanish-speaking Latino men.
BMC Med Inform Decis Mak Volume: 15 Page(s): 56
07/24/2015 Authors: Berry DL; Halpenny B; Bosco JLF; Bruyere J; Sanda MG
- Multicenter Evaluation of the Prostate Health Index to Detect Aggressive Prostate Cancer in Biopsy Naïve Men.
J Urol Volume: 194 Page(s): 65 - 72
07/01/2015 Authors: de la Calle C; Patil D; Wei JT; Scherr DS; Sokoll L; Chan DW; Siddiqui J; Mosquera JM; Rubin MA; Sanda MG
- The prostate health index selectively identifies clinically significant prostate cancer.
J Urol Volume: 193 Page(s): 1163 - 1169
04/01/2015 Authors: Loeb S; Sanda MG; Broyles DL; Shin SS; Bangma CH; Wei JT; Partin AW; Klee GG; Slawin KM; Marks LS
- COMBINING URINE PCA3 AND TMPRSS2: ERG TESTS TO REFINE PROSTATE CANCER DETECTION - VALIDATION STUDY AND HEALTH ECONOMIC ANALYSIS
Volume: 193 Page(s): E982 - E983
04/01/2015 Authors: Sanda M; Feng Z; Wei J; Howard D; Rubin M; Groskopf J; Sokoll L; Chan D; Regan M; Patil D
- MULTICENTER EVALUATION OF THE PROSTATE HEALTH INDEX (PHI) FOR DETECTION OF AGGRESSIVE PROSTATE CANCER IN BIOPSY-NAIVE MEN
Volume: 193 Page(s): E956 - E957
04/01/2015 Authors: de la Calle C; Patil D; Wei J; Scherr D; Sokoll L; Chan D; Siddiqui J; Mosquera JM; Rubin M; Sanda M
- MULTI-CENTER PROSPECTIVE STUDY OF URINE RNA TESTING AS A STRATEGY FOR PROSTATE CANCER SCREENING: COLLABORATION BETWEEN UROLOGY, PRIMARY CARE, AND COMMUNITY OUTREACH
Volume: 193 Page(s): E957 - E958
04/01/2015 Authors: Patil D; de la Calle C; Weaver B; Leach R; Thompson I; Sokoll L; Chan D; Groskopf J; Carter JJ; Torlak M
- LOCATION OF DISEASE DOES NOT IMPACT PCA3'S ABILITY TO PREDICT CANCER ON BIOPSY
Volume: 193 Page(s): E54 - E54
04/01/2015 Authors: O'Malley P; Al Awamlh BAH; Nguyen DP; Sanda MG; Thompson IM; Wei JT; Lee R; Rubin MA; Barbieri CE; Hermann MP
- REAL-WORLD USE OF EPIC FOR CLINICAL PRACTICE (EPIC-CP) TO ASSESS PATIENT-REPORTED PROSTATE CANCER QUALITY-OF-LIFE IN THE CLINICAL SETTING
Volume: 193 Page(s): E1057 - E1057
04/01/2015 Authors: Chang P; Carneiro A; Dovirak O; Taylor K; Crociani C; McAnally K; Percy A; Sanda MG; Wagner AA
- CLINICAL OUTCOMES OF CONSERVATIVELY MANAGED PROSTATE CANCER AMONG AFRICAN AMERICAN MEN
Volume: 193 Page(s): E28 - E28
04/01/2015 Authors: Patel A; Sanda M; Patil D; Issa M; Petros J
- Benchmarks for operative outcomes of robotic and open radical prostatectomy: results from the Health Professionals Follow-up Study.
Eur Urol Volume: 67 Page(s): 432 - 438
03/01/2015 Authors: Alemozaffar M; Sanda M; Yecies D; Mucci LA; Stampfer MJ; Kenfield SA
- Real-world use of epic for clinical practice (EPIC-CP) to assess patient-reported prostate cancer quality of life in the clinical setting
Volume: 33
03/01/2015 Authors: Chang P; Carneiro A; Dovirak O; Taylor K; Crociani C; Sanda MG; Percy A; McAnally K; Wagner AA
- Genomic RNAseq From Formalin Fixed Paraffin Embedded (FFPE) Prostate Needle Core Biopsies of Patients With Prostatic Adenocarcinoma
Volume: 95 Page(s): 246A - 246A
02/01/2015 Authors: Moreno C; Long Q; Sannigrahi S; Gillespie T; Petros J; Sanda M; Osunkoya A
- Genomic RNAseq From Formalin Fixed Paraffin Embedded (FFPE) Prostate Needle Core Biopsies of Patients With Prostatic Adenocarcinoma
Volume: 28 Page(s): 246A - 246A
02/01/2015 Authors: Moreno C; Long Q; Sannigrahi S; Gillespie T; Petros J; Sanda M; Osunkoya A
- Correlation of Urinary T2:ERG Fusion Detection and Tissue ERG Expression: Comprehensive Evaluation of Prostatectomy Specimens From the EDRN Study
Volume: 95 Page(s): 220A - 220A
02/01/2015 Authors: Fontugne J; Sanda M; Tomlins S; Wei J; Patil D; Ye H; Park K; Chipman J; Regan M; Scherr D
- Correlation of Urinary T2:ERG Fusion Detection and Tissue ERG Expression: Comprehensive Evaluation of Prostatectomy Specimens From the EDRN Study
Volume: 28 Page(s): 220A - 220A
02/01/2015 Authors: Fontugne J; Sanda M; Tomlins S; Wei J; Patil D; Ye H; Park K; Chipman J; Regan M; Scherr D
- Minimally important difference for the Expanded Prostate Cancer Index Composite Short Form.
Urology Volume: 85 Page(s): 101 - 105
01/01/2015 Authors: Skolarus TA; Dunn RL; Sanda MG; Chang P; Greenfield TK; Litwin MS; Wei JT; PROSTQA Consortium
- Can urinary PCA3 supplement PSA in the early detection of prostate cancer?
J Clin Oncol Volume: 32 Page(s): 4066 - 4072
12/20/2014 Authors: Wei JT; Feng Z; Partin AW; Brown E; Thompson I; Sokoll L; Chan DW; Lotan Y; Kibel AS; Busby JE
- Intense androgen-deprivation therapy with abiraterone acetate plus leuprolide acetate in patients with localized high-risk prostate cancer: results of a randomized phase II neoadjuvant study.
J Clin Oncol Volume: 32 Page(s): 3705 - 3715
11/20/2014 Authors: Taplin M-E; Montgomery B; Logothetis CJ; Bubley GJ; Richie JP; Dalkin BL; Sanda MG; Davis JW; Loda M; True LD
- Prostate cancer with Paneth cell-like neuroendocrine differentiation has recognizable histomorphology and harbors AURKA gene amplification.
Volume: 45 Page(s): 2136 - 2143
10/01/2014 Authors: Park K; Chen Z; MacDonald TY; Siddiqui J; Ye H; Erbersdobler A; Shevchuk MM; Robinson BD; Sanda MG; Chinnaiyan AM
- Early Quality of Life (QOL) Declines Correlate With Later QOL After Intensity Modulated Radiation Therapy, Low-Dose-Rate Brachytherapy, or Stereotactic Radiation for Prostate Cancer
Volume: 90 Page(s): S84 - S85
09/01/2014 Authors: Zhao S; Evans JR; Daignault-Newton S; Sanda MG; Michalski J; Sandler HM; Kuban DA; Ciezki JP; Kaplan ID; Zietman AL
- Patient-Reported Outcomes for Quality of Life (QOL) by Expanded Prostate Cancer Index (EPIC) 15 Years Posttreatment
Volume: 90 Page(s): S714 - S714
09/01/2014 Authors: Zhou J; Daignault-Newton S; Miller D; Wei J; Dunn R; Johnson S; Jackson W; Imam H; Kazzi N; McLaughlin R
- Comparative Effectiveness Analysis of Patient-Reported Quality of Life (QOL) After Stereotactic Body Radiation Therapy as Compared to Intensity Modulated Radiation Therapy or Low-Dose-Rate Brachytherapy up to 2 Years After Treatment
Volume: 90 Page(s): S409 - S409
09/01/2014 Authors: Evans JR; Zhao S; Daignault-Newton S; Sanda M; Michalski J; Sandler HM; Kuban DA; Ciezki JP; Kaplan ID; Zietman AL
- Localized prostate cancer in Norway, the United States, and Spain: between-country differences of variables before treatment among patients eligible for curative treatment.
Clin Genitourin Cancer Volume: 12 Page(s): e117 - e125
08/01/2014 Authors: Storås AH; Sanda MG; Ferrer M; Loge JH; Dahl AA; Steinsvik EAS; Guedea F; Cvancarova M; Fosså SD
- Androgens alter T-cell immunity by inhibiting T-helper 1 differentiation.
Proc Natl Acad Sci U S A Volume: 111 Page(s): 9887 - 9892
07/08/2014 Authors: Kissick HT; Sanda MG; Dunn LK; Pellegrini KL; On ST; Noel JK; Arredouani MS
- Recommended patient-reported core set of symptoms to measure in prostate cancer treatment trials.
J Natl Cancer Inst Volume: 106
07/01/2014 Authors: Chen RC; Chang P; Vetter RJ; Lukka H; Stokes WA; Sanda MG; Watkins-Bruner D; Reeve BB; Sandler HM
- Recommended patient-reported core set of symptoms to measure in head and neck cancer treatment trials.
J Natl Cancer Inst Volume: 106
07/01/2014 Authors: Chera BS; Eisbruch A; Murphy BA; Ridge JA; Gavin P; Reeve BB; Bruner DW; Movsas B
- Prostate Cancer Prevention Trial risk calculator 2.0 for the prediction of low- vs high-grade prostate cancer.
Urology Volume: 83 Page(s): 1362 - 1367
06/01/2014 Authors: Ankerst DP; Hoefler J; Bock S; Goodman PJ; Vickers A; Hernandez J; Sokoll LJ; Sanda MG; Wei JT; Leach RJ
- Satisfaction with information used to choose prostate cancer treatment.
J Urol Volume: 191 Page(s): 1265 - 1271
05/01/2014 Authors: Gilbert SM; Sanda MG; Dunn RL; Greenfield TK; Hembroff L; Klein E; Saigal CS; Pisters L; Michalski J; Sandler HM
- Comparative effectiveness study of patient-reported outcomes after proton therapy or intensity-modulated radiotherapy for prostate cancer.
Cancer Volume: 120 Page(s): 1076 - 1082
04/01/2014 Authors: Hoppe BS; Michalski JM; Mendenhall NP; Morris CG; Henderson RH; Nichols RC; Mendenhall WM; Williams CR; Regan MM; Chipman JJ
- PREDICTORS OF FAVORABLE URINARY OUTCOMES AFTER PROSTATE CANCER TREATMENT
Volume: 191 Page(s): E601 - E601
04/01/2014 Authors: Chang P; Regan M; Wei J; Hembroff L; Michalski J; Saigal C; Litwin MS; Hamstra D; Kaplan I; Ciezki J
- Measuring and predicting prostate cancer related quality of life changes using EPIC for clinical practice.
J Urol Volume: 191 Page(s): 638 - 645
03/01/2014 Authors: Chipman JJ; Sanda MG; Dunn RL; Wei JT; Litwin MS; Crociani CM; Regan MM; Chang P; PROST-QA Consortium
- Dose to the inferior rectum is strongly associated with patient reported bowel quality of life after radiation therapy for prostate cancer.
Radiother Oncol Volume: 110 Page(s): 291 - 297
02/01/2014 Authors: Stenmark MH; Conlon ASC; Johnson S; Daignault S; Litzenberg D; Marsh R; Ritter T; Vance S; Kazzi N; Feng FY
- Molecular Subclasses of Prostate Cancer: A Comprehensive Evaluation of All Tumor Foci in Radical Prostatectomy Specimens
Volume: 94 Page(s): 229A - 229A
02/01/2014 Authors: Fontugne J; Ye H; Park K; Blattner M; Siddiqui J; MacDonald T; Chinnaiyan AM; Sanda M; Barbieri CE; Rubin MA
- Molecular Subclasses of Prostate Cancer: A Comprehensive Evaluation of All Tumor Foci in Radical Prostatectomy Specimens
Volume: 27 Page(s): 229A - 229A
02/01/2014 Authors: Fontugne J; Ye H; Park K; Blattner M; Siddiqui J; MacDonald T; Chinnaiyan AM; Sanda M; Barbieri CE; Rubin MA
- Immunization with a peptide containing MHC class I and II epitopes derived from the tumor antigen SIM2 induces an effective CD4 and CD8 T-cell response.
PLoS One Volume: 9 Page(s): e93231
01/01/2014 Authors: Kissick HT; Sanda MG; Dunn LK; Arredouani MS
- Development of a peptide-based vaccine targeting TMPRSS2:ERG fusion-positive prostate cancer.
Cancer Immunol Immunother Volume: 62 Page(s): 1831 - 1840
12/01/2013 Authors: Kissick HT; Sanda MG; Dunn LK; Arredouani MS
- Neoadjuvant androgen deprivation therapy leads to immediate impairment of vitality/hormonal and sexual quality of life: results of a multicenter prospective study.
Urology Volume: 82 Page(s): 1363 - 1368
12/01/2013 Authors: Gay HA; Michalski JM; Hamstra DA; Wei JT; Dunn RL; Klein EA; Sandler HM; Saigal C; Litwin M; Kuban D
- Survivorship after prostate cancer treatment: spouses' quality of life at 36 months.
Oncol Nurs Forum Volume: 40 Page(s): 567 - 573
11/01/2013 Authors: Harden J; Sanda MG; Wei JT; Yarandi HN; Hembroff L; Hardy J; Northouse L
- Re: Urinary TMPRSS2:ERG and PCA3 in an active surveillance cohort: results from a baseline analysis in the Canary Prostate Active Surveillance Study.
J Urol Volume: 190 Page(s): 1764
11/01/2013 Authors: Taneja SS
- IMPROVING A TREATMENT DECISION SUPPORT SYSTEM FOR MINORITY MEN WITH LOCALIZED PROSTATE CANCER
ONCOLOGY NURSING FORUM Volume: 40 Page(s): E433 - E433
11/01/2013 Authors: Berry D; Sanda M; Chang P; Hayes J; Halpenny B
- Comparative Effectiveness Study of Proton Therapy Versus IMRT for Definitive Treatment of Prostate Cancer Based on Patient-Reported Outcomes
Volume: 87 Page(s): S346 - S346
10/01/2013 Authors: Hoppe BS; Michalski JM; Mendenhall NP; Morris CG; Henderson RH; Nichols RC; Regan MM; Sandler HM; Sanda MG; Hamstra DA
- Dose to the Inferior Rectum Ha's the Strongest Association With Patient-Reported Bowel. Quality of Life(QOL) After External Beam Radiation Therapy (EBRT) for Prostate Cancer
Volume: 87 Page(s): S172 - S172
10/01/2013 Authors: Stenmark MH; Johnson S; Conlon AS; Dainault S; Marsh R; Ritter T; Litzenberg D; Sandler HM; Sanda MG; Hamstra DA
- Successful Patient Acceptance of Randomization Within the Pace Study (Prostate Advances in Comparative Evidence)
Volume: 87 Page(s): S365 - S365
10/01/2013 Authors: Tree A; Aluwini S; Bryant H; Hall E; Incrocci L; Kaplan I; Ostler P; Sanda M; Thompson A; van As N
- Patient-Reported Quality of Life Outcomes in Intermediate-Risk Prostate Cancer Patients Treated With Stereotactic Body Radiation Therapy
Volume: 87 Page(s): S25 - S25
10/01/2013 Authors: Meier R; Kaplan I; Beckman A; Henning G; Woodhouse S; Williamson S; Mohideen N; Herold D; Cotrutz C; Sanda M
- Diagnosis of relevant prostate cancer using supplementary cores from magnetic resonance imaging-prompted areas following multiple failed biopsies.
Magn Reson Imaging Volume: 31 Page(s): 947 - 952
07/01/2013 Authors: Costa DN; Bloch BN; Yao DF; Sanda MG; Ngo L; Genega EM; Pedrosa I; DeWolf WC; Rofsky NM
- Multi-institutional prospective evaluation of bowel quality of life after prostate external beam radiation therapy identifies patient and treatment factors associated with patient-reported outcomes: the PROSTQA experience.
Int J Radiat Oncol Biol Phys Volume: 86 Page(s): 546 - 553
07/01/2013 Authors: Hamstra DA; Conlon ASC; Daignault S; Dunn RL; Sandler HM; Hembroff AL; Zietman AL; Kaplan I; Ciezki J; Kuban DA
- Combining urinary detection of TMPRSS2:ERG and PCA3 with serum PSA to predict diagnosis of prostate cancer.
Urol Oncol Volume: 31 Page(s): 566 - 571
07/01/2013 Authors: Salami SS; Schmidt F; Laxman B; Regan MM; Rickman DS; Scherr D; Bueti G; Siddiqui J; Tomlins SA; Wei JT
- Urinary TMPRSS2:ERG and PCA3 in an active surveillance cohort: results from a baseline analysis in the Canary Prostate Active Surveillance Study.
Clin Cancer Res Volume: 19 Page(s): 2442 - 2450
05/01/2013 Authors: Lin DW; Newcomb LF; Brown EC; Brooks JD; Carroll PR; Feng Z; Gleave ME; Lance RS; Sanda MG; Thompson IM
- Patient-reported outcomes after 3-dimensional conformal, intensity-modulated, or proton beam radiotherapy for localized prostate cancer.
Cancer Volume: 119 Page(s): 1729 - 1735
05/01/2013 Authors: Gray PJ; Paly JJ; Yeap BY; Sanda MG; Sandler HM; Michalski JM; Talcott JA; Coen JJ; Hamstra DA; Shipley WU
- Prospective multicenter evaluation of the Beckman Coulter Prostate Health Index using WHO calibration.
J Urol Volume: 189 Page(s): 1702 - 1706
05/01/2013 Authors: Loeb S; Sokoll LJ; Broyles DL; Bangma CH; van Schaik RHN; Klee GG; Wei JT; Sanda MG; Partin AW; Slawin KM
- Androgens modulate anti-tumor immunity through interference with the T lymphocyte differentiation program
Volume: 190
05/01/2013 Authors: Arredouani MS; Kissick H; Dunn L; Sanda M
- EFFECT OF NEOADJUVANT ABIRATERONE ACETATE PLUS LEUPROLIDE ACETATE ON PSA, PATHOLOGIC RESPONSE, AND INTRAPROSTATIC/SERUM ANDROGEN LEVELS IN LOCALIZED HIGH-RISK PROSTATE CANCER: RESULTS OF A RANDOMIZED PHASE 2 STUDY
Volume: 189 Page(s): E272 - E272
04/01/2013 Authors: Richie JP; Montgomery RB; Logothetis CJ; Bubley GJ; Dalkin BL; Sanda MG; Loda MF; Lis RT; True LD; Troncoso P
- PROSTATE HEALTH INDEX (PHI) FOR REDUCING OVERDETECTION OF INDOLENT PROSTATE CANCER AND UNNECESSARY BIOPSY WHILE IMPROVING DETECTION OF AGGRESSIVE CANCERS
Volume: 189 Page(s): E843 - E843
04/01/2013 Authors: Sanda M; Wei J; Broyles D; Shin S; Partin A; Klee G; Bangma C; Slawin K; Marks L; Cruz A
- NOMOGRAM PREDICTING URINARY INCONTINENCE FOR MEN WITH LOCALIZED PROSTATE CANCER TREATED BY RADICAL PROSTATECTOMY, EXTERNAL-BEAM RADIOTHERAPY, AND BRACHYTHERAPY
Volume: 189 Page(s): E178 - E179
04/01/2013 Authors: Klink J; Sanda M; Litwin M; Ferrer M; Regan M; Saigal C; Kwan L; Gao T; Rabah D; Klein E
- Uncertainty and perception of danger among patients undergoing treatment for prostate cancer.
BJU Int Volume: 111 Page(s): E84 - E91
03/01/2013 Authors: Kazer MW; Bailey DE; Chipman J; Psutka SP; Hardy J; Hembroff L; Regan M; Dunn RL; Crociani C; Sanda MG
- Prediction of patient-reported bowel quality of life (QOL) after dose-escalated radiation therapy (RT) for prostate cancer by rectal dosimetry.
Volume: 31 Page(s): 84
02/20/2013 Authors: Conlon ASC; Daignault S; Bassetti MF; Vance S; Marsh R; Litzenberg D; Ritter T; Feng FY-C; Sandler HM; Sanda MG
- Association of declining PSA values with a lower risk of progression in the Canary Prostate Cancer Active Surveillance Study (PASS)
Volume: 31
02/20/2013 Authors: Brooks JD; Brown EC; Cooperberg MR; Newcomb LF; Carroll P; Feng Z; Gleave ME; Lance R; Sanda MG; Thompson IM
- Association of declining PSA values with a lower risk of progression in the Canary Prostate Cancer Active Surveillance Study (PASS).
J Clin Oncol Volume: 31 Page(s): 88
02/20/2013 Authors: Brown EC; Cooperberg MR; Newcomb LF; Carroll P; Feng Z; Gleave ME; Lance R; Sanda MG; Thompson IM; Wei JT
- Partners' long-term appraisal of their caregiving experience, marital satisfaction, sexual satisfaction, and quality of life 2 years after prostate cancer treatment.
Cancer Nurs Volume: 36 Page(s): 104 - 113
01/01/2013 Authors: Harden JK; Sanda MG; Wei JT; Yarandi H; Hembroff L; Hardy J; Northouse LL; PROSTQA Consortium Study Group
- Nomogram predicting treatment-related urinary incontinence for men with localized prostate cancer treated by radical prostatectomy (RP), external-beam radiotherapy (EBRT), or brachytherapy (PI)
JOURNAL OF CLINICAL ONCOLOGY Volume: 30
12/01/2012 Authors: Klink JC; Sanda MG; Litwin MS; Ferrer M; Regan MM; Saigal C; Kwan L; Gao T; Klein EA; Kattan MW
- Nomogram predicting treatment-related sexual dysfunction for men with localized prostate cancer treated by radical prostatectomy (RP), external-beam radiotherapy (EBRT), and brachytherapy (PI)
JOURNAL OF CLINICAL ONCOLOGY Volume: 30
12/01/2012 Authors: Klink JC; Sanda MG; Litwin MS; Ferrer M; Regan MM; Saigal C; Kwan L; Gao T; Klein EA; Kattan MW
- Nomogram predicting treatment- related bowel dysfunction for men with localized prostate cancer treated by radical prostatectomy (RP), external-beam radiotherapy (EBRT), and brachytherapy (PI)
JOURNAL OF CLINICAL ONCOLOGY Volume: 30
12/01/2012 Authors: Klink JC; Michalski JM; Sanda MG; Litwin MS; Ferrer M; Hamstra DA; Regan MM; Saigal C; Kwan L; Gao T
- Patient-reported Quality of Life in Prostate Cancer Patients Treated With 3D Conformal Intensity Modulated or Proton Beam Radiation Therapy
Volume: 84 Page(s): S13 - S13
11/01/2012 Authors: Gray PJ; Paly JJ; Yeap B; Sanda MG; Talcott JA; Sandler HM; Michalski JM; Hamstra DA; Bekelman JE; Efstathiou JA
- Stereotactic Body Radiation Therapy for Intermediate-risk Organ-confined Prostate Cancer: Interim Toxicity and Quality of Life Outcomes From a Multi-institutional Study
Volume: 84 Page(s): S148 - S148
11/01/2012 Authors: Meier R; Kaplan I; Beckman A; Henning G; Woodhouse S; Williamson S; Mohideen N; Herold D; Cotrutz C; Sanda M
- Prediction of prostate cancer extracapsular extension with high spatial resolution dynamic contrast-enhanced 3-T MRI.
Eur Radiol Volume: 22 Page(s): 2201 - 2210
10/01/2012 Authors: Bloch BN; Genega EM; Costa DN; Pedrosa I; Smith MP; Kressel HY; Ngo L; Sanda MG; Dewolf WC; Rofsky NM
- The TMPRSS2:ERG rearrangement, ERG expression, and prostate cancer outcomes: a cohort study and meta-analysis.
Cancer Epidemiol Biomarkers Prev Volume: 21 Page(s): 1497 - 1509
09/01/2012 Authors: Pettersson A; Graff RE; Bauer SR; Pitt MJ; Lis RT; Stack EC; Martin NE; Kunz L; Penney KL; Ligon AH
- Evaluation of patient-reported quality-of-life outcomes after renal surgery.
Urology Volume: 79 Page(s): 1268 - 1273
06/01/2012 Authors: Kim SB; Williams SB; Cheng S-C; Sanda MG; Wagner AA
- Selective detection of histologically aggressive prostate cancer: an Early Detection Research Network Prediction model to reduce unnecessary prostate biopsies with validation in the Prostate Cancer Prevention Trial.
Cancer Volume: 118 Page(s): 2651 - 2658
05/15/2012 Authors: Williams SB; Salami S; Regan MM; Ankerst DP; Wei JT; Rubin MA; Thompson IM; Sanda MG
- Distinct transcriptome of regulatory T cells in prostate cancer
Volume: 188
05/01/2012 Authors: Arredouani MS; Kissick H; Dunn L; Sanda M
- Metabolic profiling of T-cell differentiation and tolerance
Volume: 188
05/01/2012 Authors: Kissick H; Finke J; Dunn L; Asara J; Sanda M; Arredouani MS
- Immunogenic Peptides Derived from the Transcription Factor ERG as a Vaccine for Prostate Cancer
Volume: 188
05/01/2012 Authors: Kissick H; Dunn L; Lu B; Sanda M; Arredouani MS
- Breaking immune tolerance to prostate-associated tumor antigens through Tim-1 receptor
Volume: 188
05/01/2012 Authors: Arredouani MS; Kissick H; Dunn L; Strom T; Sanda M
- Identification of functionally active, low frequency copy number variants at 15q21.3 and 12q21.31 associated with prostate cancer risk.
Proc Natl Acad Sci U S A Volume: 109 Page(s): 6686 - 6691
04/24/2012 Authors: Demichelis F; Setlur SR; Banerjee S; Chakravarty D; Chen JYH; Chen CX; Huang J; Beltran H; Oldridge DA; Kitabayashi N
- The NCI Early Detection Research Network (EDRN) urinary PCA3 validation trial
CANCER RESEARCH Volume: 72
04/15/2012 Authors: Wei JT; Sanda MG; Thompson IM; Partin A; Feng Z; Sokoll L; Groskopf J; Brown E; Lotan Y; Kibel A
- SURGEON VARIANCE IN PATIENT-REPORTED AND CLINICAL OUTCOMES OF RETROPUBIC, LAPAROSCOPIC, OR ROBOTIC RADICAL PROSTATECTOMY
Volume: 187 Page(s): E732 - E732
04/01/2012 Authors: Sanda M; Chipman J; Wei J; Hembroff L; Hollenbeck B; Wood D; Saigal C; Litwin M; Hu J; Dahl D
- INCORPORATION OF BODY MASS INDEX AND PROSTATE SIZE INTO A NOMOGRAM FOR SELECTING PATIENTS FOR INITIAL PROSTATE BIOPSY: VALIDATION IN THE PROSTATE CANCER PREVENTION TRIAL
Volume: 187 Page(s): E493 - E493
04/01/2012 Authors: Salami S; Regan M; Wei J; Ankerst D; Williams S; Scherr D; Bueti G; Siddiqui J; DeWolf W; Kearney M
- ALLEVIATION VERSUS INDUCTION OF URINARY OBSTRUCTION OR INCONTINENCE BY PROSTATE CANCER TREATMENT: THE PIVOTAL ROLE OF PRETREATMENT URINARY SYMPTOMS
Volume: 187 Page(s): E283 - E283
04/01/2012 Authors: Chang P; Regan M; Stephenson A; Ferrer M; Wei J; Hembroff L; Francisco Suarez J; Michalski J; Saigal C; Litwin M
- THE NCI EARLY DETECTION RESEARCH NETWORK (EDRN) URINARY PCA3 VALIDATION TRIAL
Volume: 187 Page(s): E889 - E890
04/01/2012 Authors: Wei J; Sanda M; Thompson I; Partin A; Feng Z; Sokoll L; Groskopf J; Brown E; Lotan Y; Kibel A
- PROGRESSION AND TREATMENT IN A MULTI-INSTITUTIONAL, PROSPECTIVE ACTIVE SURVEILLANCE STUDY: RESULTS FROM CANARY PROSTATE ACTIVE SURVEILLANCE STUDY (PASS)
Volume: 187 Page(s): E403 - E403
04/01/2012 Authors: Lin D; Newcomb L; Ellis W; Gleave M; Thompson I; Brooks J; Nelson P; Sanda M; Lance R; Wei J
- THE EXPANDED PROSTATE CANCER INDEX COMPOSITE FOR CLINICAL PRACTICE (EPIC-CP) IS SENSITIVE TO TREATMENT-RELATED QUALITY OF LIFE CHANGES OVER TIME: VALIDATION USING THE PROST-QA COHORT
Volume: 187 Page(s): E458 - E459
04/01/2012 Authors: Chang P; Chipman J; Regan M; Wei J; Dunn R; Litwin M; Sanda M
- Urinary TMPRSS2: Use of ERG and PCA3 to predict tumor volume and Gleason grade in an active surveillance cohort-Results from the Canary/EDRN Prostate Active Surveillance Study
JOURNAL OF CLINICAL ONCOLOGY Volume: 30
02/10/2012 Authors: Lin DW; Newcomb LF; Brown EC; Brooks JD; Carroll P; Feng Z; Gleave ME; Lance R; Sanda MG; Thompson IM
- Bowel and bladder toxicity patterns in patients with prostate cancer treated with proton beam versus intensity-modulated radiation therapy
JOURNAL OF CLINICAL ONCOLOGY Volume: 30
02/10/2012 Authors: Gray PJ; Paly JJ; Sanda MG; Sandler HM; Michalski JM; Talcott JA; Coen J; Shipley WU; Zietman AL; Bekelman JE
- Urinary TMPRSS2: Use of ERG and PCA3 to predict tumor volume and Gleason grade in an active surveillance cohort-Results from the Canary/EDRN Prostate Active Surveillance Study.
J Clin Oncol Volume: 30 Page(s): 2
02/10/2012 Authors: Lin DW; Newcomb LF; Brown EC; Brooks JD; Carroll P; Feng Z; Gleave ME; Lance R; Sanda MG; Thompson IM
- Bowel and bladder toxicity patterns in patients with prostate cancer treated with proton beam versus intensity-modulated radiation therapy.
J Clin Oncol Volume: 30 Page(s): 22
02/10/2012 Authors: Gray PJ; Paly JJ; Sanda MG; Sandler HM; Michalski JM; Talcott JA; Coen J; Shipley WU; Zietman AL; Bekelman JE
- Evaluation of Novel ERG/SPINK1 IHC and 4-Color Quantum-Dot Based ERG/PTEN FISH in Radical Prostatectomy Specimens
Volume: 25 Page(s): 233A - 233A
02/01/2012 Authors: Park K; Palanisamy N; MacDonald T; Siddiqui J; Chinnaiyan AM; Sanda MG; Ye H; Rubin MA; Mosquera JM
- Outcomes session.
Urol Oncol Volume: 30 Page(s): 952 - 955
01/01/2012 Authors: Penson DF; Barocas DA; Fleshner N; Sanda MG; Greenfield S
- Updating risk prediction tools: a case study in prostate cancer.
Biom J Volume: 54 Page(s): 127 - 142
01/01/2012 Authors: Ankerst DP; Koniarski T; Liang Y; Leach RJ; Feng Z; Sanda MG; Partin AW; Chan DW; Kagan J; Sokoll L
- Watchful waiting and quality of life among prostate cancer survivors in the Physicians' Health Study.
J Urol Volume: 186 Page(s): 1862 - 1867
11/01/2011 Authors: Kasperzyk JL; Shappley WV; Kenfield SA; Mucci LA; Kurth T; Ma J; Stampfer MJ; Sanda MG
- Racial/ethnic differences in receipt of pelvic lymph node dissection among men with localized/regional prostate cancer.
Cancer Volume: 117 Page(s): 4651 - 4658
10/15/2011 Authors: Hayn MH; Orom H; Shavers VL; Sanda MG; Glasgow M; Mohler JL; Underwood W
- Prediction of erectile function following treatment for prostate cancer.
JAMA Volume: 306 Page(s): 1205 - 1214
09/21/2011 Authors: Alemozaffar M; Regan MM; Cooperberg MR; Wei JT; Michalski JM; Sandler HM; Hembroff L; Sadetsky N; Saigal CS; Litwin MS
- Expanded prostate cancer index composite for clinical practice: development and validation of a practical health related quality of life instrument for use in the routine clinical care of patients with prostate cancer.
J Urol Volume: 186 Page(s): 865 - 872
09/01/2011 Authors: Chang P; Szymanski KM; Dunn RL; Chipman JJ; Litwin MS; Nguyen PL; Sweeney CJ; Cook R; Wagner AA; DeWolf WC
- An Internet intervention for management of uncertainty during active surveillance for prostate cancer.
Oncol Nurs Forum Volume: 38 Page(s): 561 - 568
09/01/2011 Authors: Kazer MW; Bailey DE; Sanda M; Colberg J; Kelly WK
- Urine TMPRSS2:ERG fusion transcript stratifies prostate cancer risk in men with elevated serum PSA.
Sci Transl Med Volume: 3 Page(s): 94ra72
08/03/2011 Authors: Tomlins SA; Aubin SMJ; Siddiqui J; Lonigro RJ; Sefton-Miller L; Miick S; Williamsen S; Hodge P; Meinke J; Blase A
- The experiences of unpartnered men with prostate cancer: a qualitative analysis.
J Cancer Surviv Volume: 5 Page(s): 132 - 141
06/01/2011 Authors: Kazer MW; Harden J; Burke M; Sanda MG; Hardy J; Bailey DE; PROSTQA Study Group
- A multicenter study of [-2]pro-prostate specific antigen combined with prostate specific antigen and free prostate specific antigen for prostate cancer detection in the 2.0 to 10.0 ng/ml prostate specific antigen range.
J Urol Volume: 185 Page(s): 1650 - 1655
05/01/2011 Authors: Catalona WJ; Partin AW; Sanda MG; Wei JT; Klee GG; Bangma CH; Slawin KM; Marks LS; Loeb S; Broyles DL
- BENCHMARKS FOR OPERATIVE OUTCOMES OF ROBOTIC LAPAROSCOPIC AND OPEN RADICAL PROSTATECTOMY BASED ON RESULTS FROM A NATIONWIDE AMERICAN COHORT: THE HEALTH PROFESSIONALS FOLLOW-UP STUDY
Volume: 185 Page(s): E715 - E715
04/01/2011 Authors: Alemozaffar M; Sanda M; Yecies D; Stampfer M; Kenfield S
- PERSONALIZED PREDICTION OF ERECTION RECOVERY AFTER PRIMARY PROSTATE CANCER TREATMENT: VALIDATION IN THE COMMUNITY-BASED CAPSURE COHORT OF A PREDICTIVE MODEL DEVELOPED IN PROSTQA
Volume: 185 Page(s): E616 - E617
04/01/2011 Authors: Alemozaffar M; Sanda M; Sadetsky N; Regan M; Carroll P; Cooperberg M
- INTERNET-BASED EVALUATION OF QUALITY-OF-LIFE OUTCOMES AFTER ROBOTIC, LAPAROSCOPIC, AND OPEN RADICAL OR PARTIAL NEPHRECTOMY
Volume: 185 Page(s): E433 - E433
04/01/2011 Authors: Kim SB; Cheng S-C; Mongiu AK; Sanda MG; Wagner AA
- EVALUATION OF THE PROSTATE HEALTH INDEX (PHI)(1) IN THE 2 TO 4, AND 4 TO 10 NG/ML PSA RANGES: RESULTS FROM A MULTI-SITE, PROSPECTIVE, CLINICAL EVALUATION
Volume: 185 Page(s): E396 - E396
04/01/2011 Authors: Catalona WJ; Sanda MG; Wei JT; Klee GG; Bangma CH; Slawin KM; Marks LS; Loeb S; Broyles DL; Shin SS
- Evaluation of the SCA instrument for measuring patient satisfaction with cancer care administered via paper or via the Internet.
Ann Oncol Volume: 22 Page(s): 723 - 729
03/01/2011 Authors: Kamo N; Dandapani SV; Miksad RA; Houlihan MJ; Kaplan I; Regan M; Greenfield TK; Sanda MG
- The role of the transcription factor SIM2 in prostate cancer.
PLoS One Volume: 6 Page(s): e28837
01/01/2011 Authors: Lu B; Asara JM; Sanda MG; Arredouani MS
- Editorial comment. Acute lower urinary tract symptoms after prostate brachytherapy with cesium-131.
Urology Volume: 76 Page(s): 1148
11/01/2010 Authors: Sanda MG
- Urinary obstructive problems exposed but hormonal health-related quality-of-life concerns eschewed in prostate cancer quality-of-life study.
J Clin Oncol Volume: 28 Page(s): 4667 - 4668
11/01/2010 Authors: Sanda MG
- Development and validation of an abbreviated version of the expanded prostate cancer index composite instrument for measuring health-related quality of life among prostate cancer survivors.
Urology Volume: 76 Page(s): 1245 - 1250
11/01/2010 Authors: Szymanski KM; Wei JT; Dunn RL; Sanda MG
- Comparison of validated instruments measuring sexual function in men.
Urology Volume: 76 Page(s): 380 - 386
08/01/2010 Authors: Levinson AW; Ward NT; Sanda MG; Mettee LZ; Wei JT; Su L-M; Litwin MS; Pavlovich CP
- Defective NKT cell activation by CD1d+ TRAMP prostate tumor cells is corrected by interleukin-12 with α-galactosylceramide.
PLoS One Volume: 5 Page(s): e11311
06/25/2010 Authors: Nowak M; Arredouani MS; Tun-Kyi A; Schmidt-Wolf I; Sanda MG; Balk SP; Exley MA
- Androgen ablation augments human HLA2.1-restricted T cell responses to PSA self-antigen in transgenic mice.
Prostate Volume: 70 Page(s): 1002 - 1011
06/15/2010 Authors: Arredouani MS; Tseng-Rogenski SS; Hollenbeck BK; Escara-Wilke J; Leander KR; Defeo-Jones D; Hwang C; Sanda MG
- A prospective, multicenter, National Cancer Institute Early Detection Research Network study of [-2]proPSA: improving prostate cancer detection and correlating with cancer aggressiveness.
Cancer Epidemiol Biomarkers Prev Volume: 19 Page(s): 1193 - 1200
05/01/2010 Authors: Sokoll LJ; Sanda MG; Feng Z; Kagan J; Mizrahi IA; Broyles DL; Partin AW; Srivastava S; Thompson IM; Wei JT
- The 'CaP Calculator': an online decision support tool for clinically localized prostate cancer.
BJU Int Volume: 105 Page(s): 1417 - 1422
05/01/2010 Authors: Katz MS; Efstathiou JA; D'Amico AV; Kattan MW; Sanda MG; Nguyen PL; Smith MR; Carroll PR; Zietman AL
- Reduction in patient-reported acute morbidity in prostate cancer patients treated with 81-Gy Intensity-modulated radiotherapy using reduced planning target volume margins and electromagnetic tracking: assessing the impact of margin reduction study.
Urology Volume: 75 Page(s): 1004 - 1008
05/01/2010 Authors: Sandler HM; Liu P-Y; Dunn RL; Khan DC; Tropper SE; Sanda MG; Mantz CA
- COMBINING TMPRSS2: ERG AND PCA3 IN POST-DRE URINE WITH SERUM PSA TO IDENTIFY PROSTATE BIOPSY CANDIDATES: DEVELOPMENT AND VERIFICATION OF A CLINICALLY PRACTICAL ALGORITHM
Volume: 183 Page(s): E839 - E839
04/01/2010 Authors: Tomlins S; Sanda M; Salami S; Laxman B; Regan M; Siddiqui J; Rickman D; Scherr D; Rubin M; Wei J
- EVALUATION OF [-2]PROPSA IN COMBINATION WITH PSA AND FREE PSA, USING THE BECKMAN COULTER ACCESS IMMUNOASSAY SYSTEMS, FOR IDENTIFYING PATIENTS WITH AGGRESSIVE PROSTATE CANCER. A MULTI-CENTER PROSPECTIVE CLINICAL EVALUATION.
Volume: 183 Page(s): E56 - E56
04/01/2010 Authors: Catalona WJ; Sanda MG; Wei JT; Klee GG; Slawin KM; Marks LS; Bangma CH; Chan DW; Sokoll LJ; Roberts WL
- [-2]PROPSA IN COMBINATION WITH PSA AND FREE-PSA, USING THE BECKMAN COULTER ACCESS IMMUNOASSAY SYSTEMS IMPROVES PROSTATE CANCER DETECTION RELATIVE TO PSA AND FREE PSA. A MULTI-CENTER PROSPECTIVE CLINICAL STUDY.
Volume: 183 Page(s): E717 - E717
04/01/2010 Authors: Catalona WJ; Sanda MG; Wei JT; Klee GG; Slawin KM; Marks LS; Bangma CH; Chan DW; Sokoll LJ; Roberts WL
- Exploiting the Good Guys: Th1 Antiviral & Antitumor Human & Mouse NKT Cells
Volume: 135 Page(s): S34 - S34
01/01/2010 Authors: Exley M; Nowak M; Yue S; Scheuplein F; Arredouani MS; Sanda M; Sasada T; Balk S
- Validation in a multiple urology practice cohort of the Prostate Cancer Prevention Trial calculator for predicting prostate cancer detection.
J Urol Volume: 182 Page(s): 2653 - 2658
12/01/2009 Authors: Eyre SJ; Ankerst DP; Wei JT; Nair PV; Regan MM; Bueti G; Tang J; Rubin MA; Kearney M; Thompson IM
- A Branched DNA Assay for Detecting TMPRSS2-ERG Fusions.
Urology Volume: 74 Page(s): 1162
11/01/2009 Authors: Sanda MG
- Detection of TMPRSS2-ERG fusion gene expression in prostate cancer specimens by a novel assay using branched DNA.
Urology Volume: 74 Page(s): 1156 - 1161
11/01/2009 Authors: Lu B; Maqsodi B; Yang W; McMaster GK; Perner S; Regan M; Bubley GJ; Balk SP; Rubin M; Sanda MG
- Androgen Ablation Augments Cellular Immune Responses to PSA in a Humanized PSA/HLA-A2.1 Transgenic Mouse Model
Volume: 32 Page(s): 966 - 966
11/01/2009 Authors: Arredouani MS; Tseng-Rogenski S; Hollenbeck B; Defeo-Jones D; Hwang C; Sanda MG
- Prospective study of determinants and outcomes of deferred treatment or watchful waiting among men with prostate cancer in a nationwide cohort.
J Clin Oncol Volume: 27 Page(s): 4980 - 4985
10/20/2009 Authors: Shappley WV; Kenfield SA; Kasperzyk JL; Qiu W; Stampfer MJ; Sanda MG; Chan JM
- Prostate cancer screening and surveillance.
JAMA Volume: 302 Page(s): 1529
10/14/2009 Authors: Rogers CS
- Further perspectives on treating localized prostate cancer.
Oncology (Williston Park) Volume: 23 Page(s): 964 - 966
10/01/2009 Authors: Aronovitz JA; Sanda MG
- Brachytherapy or Surgery? A Composite View Further Perspectives on Treating Localized Prostate Cancer The Ciezki/Klein Article Reviewed
ONCOLOGY-NEW YORK Volume: 23 Page(s): 964 - 966
10/01/2009 Authors: Aronovitz JA; Sanda MG
- Identification of the transcription factor single-minded homologue 2 as a potential biomarker and immunotherapy target in prostate cancer.
Clin Cancer Res Volume: 15 Page(s): 5794 - 5802
09/15/2009 Authors: Arredouani MS; Lu B; Bhasin M; Eljanne M; Yue W; Mosquera J-M; Bubley GJ; Li V; Rubin MA; Libermann TA
- Prevalence of TMPRSS2-ERG fusion prostate cancer among men undergoing prostate biopsy in the United States.
Clin Cancer Res Volume: 15 Page(s): 4706 - 4711
07/15/2009 Authors: Mosquera J-M; Mehra R; Regan MM; Perner S; Genega EM; Bueti G; Shah RB; Gaston S; Tomlins SA; Wei JT
- Expanded Prostate Cancer Index Composite Versus Incontinence Symptom Index and Sexual Health Inventory for Men to Measure Functional Outcomes After Prostatectomy EDITORIAL COMMENT
JOURNAL OF UROLOGY Volume: 182 Page(s): 228 - 228
07/01/2009 Authors: Sanda MG
- Editorial comment. Nerve sparing during radical prostatectomy is associated with better recovery of urinary continence.
Urology Volume: 73 Page(s): 1340 - 1341
06/01/2009 Authors: Sanda MG
- A 64-year-old man with low-risk prostate cancer: review of prostate cancer treatment.
JAMA Volume: 301 Page(s): 2141 - 2151
05/27/2009 Authors: Sanda MG; Kaplan ID
- Live longer but not better...yet.
Lancet Oncol Volume: 10 Page(s): 313 - 314
04/01/2009 Authors: Sanda MG
- PREDICTING ERECTION RECOVERY AFTER PROSTATECTOMY: A MULTIVARIABLE NOMOGRAM FROM THE PROSTQA CONSORTIUM
Volume: 181 Page(s): 759 - 759
04/01/2009 Authors: Sanda MG; Regan MM; Dunn RL; Kibel AS; Saigal CS; Litwin MS; Klein EA; Pisters LL; Wood DP; Hollenbeck BK
- [-2]PROPSA FOR PROSTATE CANCER DETECTION: A PROSPECTIVE, MULTICENTER, NCI EARLY DETECTION RESEARCH NETWORK STUDY
Volume: 181 Page(s): 772 - 772
04/01/2009 Authors: Sokoll LJ; Liu Y; Feng Z; Kagan J; Partin AW; Srivastava S; Thompson IM; Antonio S; Wei JT; Elliott D
- UTILIZATION OF MEDICATIONS AND DEVICES FOR ERECTILE DYSFUNCTION AFTER PROSTATE CANCER TREATMENT: RESULTS FROM THE MULTICENTER PROSTQA CONSORTIUM
Volume: 181 Page(s): 370 - 370
04/01/2009 Authors: Sanda MG; Regan MM; Dunn RL; Michalski J; Kibel AS; Sandler HM; Saigal CS; Hembroff L; Klein EA; Ciezki JP
- PREDICTING URINARY FUNCTION AFTER PROSTATE CANCER TREATMENT: A MULTIVARIABLE NOMOGRAM FROM THE PROSTQA CONSORTIUM
Volume: 181 Page(s): 758 - 758
04/01/2009 Authors: Sanda MG; Regan MM; Dunn RL; Michalski J; Kibel AS; Sandler HM; Litwin MS; Saigal CS; Hembroff L; Klein EA
- DISCERNING RISK OF CLINICALLY SIGNIFICANT VERSUS INDOLENT PROSTATE CANCER PRIOR TO BIOPSY: PREDICTIVE MODEL FROM A MULTI-CENTER COHORT
Volume: 181 Page(s): 774 - 774
04/01/2009 Authors: Williams SB; Regan MM; Wei JT; Kearney M; DeWolf WC; Tang J; Bueti G; Rubin M; Genega E; Eyre A
- INCREASED POSITIVE YIELD OF CLINICALLY SIGNIFICANT PROSTATE CANCER WITH MRI PROMPTED BIOPSIES
Volume: 181 Page(s): 782 - 783
04/01/2009 Authors: Yao DF; DeWdlf WC; Sanda MG; Bloch BN; Genega EM; Berry AM; Ngo L; Rofsky NM
- Health-related quality-of-life effects of watchful waiting re-evaluated in SPCG-4.
Nat Clin Pract Urol Volume: 6 Page(s): 124 - 125
03/01/2009 Authors: McDermott DW; Sanda MG
- A safety-modified SV40 Tag developed for human cancer immunotherapy.
Drug Des Devel Ther Volume: 2 Page(s): 17 - 24
02/06/2009 Authors: Tseng-Rogenski SS; Arredouani MS; Escara-Wilke JF; Neeley YC; Imperiale MJ; Sanda MG